In contrast, the incidence of acute and late genitourinary (GU) toxicities was higher after LDR-BT boost, and there was a nonsignificant trend for worse gastrointestinal (GI) morbidity 5 .
← all excerpts
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
1
—
—